Latest News in the pharma Industry

Market News

Vectura and Pulmatrix sign branded generic tiotropium bromide development agreement

Vectura and Pulmatrix sign branded generic tiotropium bromide development agreement

6 Sep 2017

Major new tiotropium bromide DPI development programme accelerated through licensing of Pulmatrix technology.

Read more 
Life-extending pancreatic cancer medicine recommended by NICE in final guidance

Life-extending pancreatic cancer medicine recommended by NICE in final guidance

6 Sep 2017

The pivotal Phase III study demonstrated that treatment with Abraxane in combination with gemcitabine can offer patients a median overall survival improvement of 1.8 months.

Read more 
Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in immuno-oncology

Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in immuno-oncology

6 Sep 2017

Rigontec’s immuno-oncology approach of engaging the innate immune system to safely eliminate cancer cells complements Merck's strategy and current pipeline.

Read more 
Novartis CEO, Joseph Jimenez, to retire from Novartis in 2018

Novartis CEO, Joseph Jimenez, to retire from Novartis in 2018

5 Sep 2017

Vasant Narasimhan appointed CEO, effective 1February 2018.

Read more 
SGS Clinical Research strengthens its consultancy service to accelerate drugs through early phase development

SGS Clinical Research strengthens its consultancy service to accelerate drugs through early phase development

5 Sep 2017

Company consolidates its consultancy portfolio into a single, comprehensive offering.

Read more 
Catalent signs commercial manufacturing agreement with US WorldMeds for lofexidine

Catalent signs commercial manufacturing agreement with US WorldMeds for lofexidine

5 Sep 2017

Lofexidine is an investigational drug under development to mitigate symptoms associated with opioid withdrawal.

Read more 
Clintec expands UK headquarters and is presented with Queens Award for Enterprise – International Trade

Clintec expands UK headquarters and is presented with Queens Award for Enterprise – International Trade

5 Sep 2017

Company's additional 4327-sq ft floor at Clintec’s Glasgow-based headquarters forms a fully dedicated centre of excellence for clinical research and quality assurance capabilities.

Read more 
Takeda disappointed as NICE issue second negative draft decision for ixazomib

Takeda disappointed as NICE issue second negative draft decision for ixazomib

5 Sep 2017

Company says it is determined to work collaboratively to find a solution.

Read more 
Janssen enters exclusive distribution agreement for Invokana and Vokanamet

Janssen enters exclusive distribution agreement for Invokana and Vokanamet

4 Sep 2017

Distribution agreement covers countries in the EEA and Switzerland.

Read more 
3SBio accelerates expansion of its global biologics platform

3SBio accelerates expansion of its global biologics platform

3 Sep 2017

The Chinese biopharmaceutical company acquires the Canadian biomanufacturing business of Therapure.

Read more 
Merck successfully closes biosimilars transaction

Merck successfully closes biosimilars transaction

1 Sep 2017

Step towards strategic alignment of R&D resources to Healthcare priorities.

Read more 
FDA approves Pfizer's Mylotarg for treatment of AML

FDA approves Pfizer's Mylotarg for treatment of AML

1 Sep 2017

Only approved antibody-drug conjugate for newly diagnosed and relapsed or refractory CD33-positive AML.

Read more